Karam JA - Search Results

1

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.

Wood CG, Ferguson JE 3rd, Parker JS, Moore DT, Whisenant JG, Maygarden SJ, Wallen EM, Kim WY, Milowsky MI, Beckermann KE, Davis NB, Haake SM, Karam JA, Bortone DS, Vincent BG, Powles T, Rathmell WK. Wood CG, et al. Among authors: karam ja. JCI Insight. 2020 Nov 19;5(22):e132852. doi: 10.1172/jci.insight.132852. JCI Insight. 2020. PMID: 33208553 Free PMC article. Clinical Trial.

2

Editorial comment.

Karam JA, Wood CG. Karam JA, et al. J Urol. 2010 Mar;183(3):870; discussion 870. doi: 10.1016/j.juro.2009.11.080. Epub 2010 Jan 18. J Urol. 2010. PMID: 20083268 No abstract available.

3

Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma.

Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Karam JA, et al. J Urol. 2010 Nov;184(5):1882-7. doi: 10.1016/j.juro.2010.06.109. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846689 Free PMC article.

4

Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM. Karam JA, et al. J Urol. 2011 Feb;185(2):439-44. doi: 10.1016/j.juro.2010.09.086. Epub 2010 Dec 17. J Urol. 2011. PMID: 21167518 Free PMC article.

5

Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.

Karam JA, Zhang XY, Tamboli P, Margulis V, Wang H, Abel EJ, Culp SH, Wood CG. Karam JA, et al. Eur Urol. 2011 Apr;59(4):619-28. doi: 10.1016/j.eururo.2010.11.043. Epub 2010 Dec 8. Eur Urol. 2011. PMID: 21167632

6

The dark side of targeted therapy.

Karam JA, Wood CG. Karam JA, et al. Eur Urol. 2011 Apr;59(4):541-2. doi: 10.1016/j.eururo.2011.01.041. Epub 2011 Feb 1. Eur Urol. 2011. PMID: 21295398 No abstract available.

7

The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.

Cost NG, Delacroix SE Jr, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. Cost NG, et al. Among authors: karam ja. Eur Urol. 2011 Jun;59(6):912-8. doi: 10.1016/j.eururo.2011.02.032. Epub 2011 Feb 23. Eur Urol. 2011. PMID: 21367518

8

The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.

Karam JA, Wood CG. Karam JA, et al. Hematol Oncol Clin North Am. 2011 Aug;25(4):753-64. doi: 10.1016/j.hoc.2011.05.002. Hematol Oncol Clin North Am. 2011. PMID: 21763966 Review.

9

Management of small renal masses: watch, cut, freeze, or fry?

Karam JA, Wood CG. Karam JA, et al. Eur Urol. 2012 May;61(5):905-6; discussion 906-7. doi: 10.1016/j.eururo.2012.01.042. Epub 2012 Feb 1. Eur Urol. 2012. PMID: 22310973 No abstract available.

10

The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?

Karam JA, Wood CG. Karam JA, et al. Eur Urol. 2012 Jul;62(1):136-8; discussion 138-9. doi: 10.1016/j.eururo.2012.02.058. Epub 2012 Mar 8. Eur Urol. 2012. PMID: 22410575 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters